Sign in

CIK 0001674416 · Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
operating
EIN
473173478
Phone
6173154600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,881,673
in 7 filings, $1.5M under 10b5-1 plans

Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Kulkarni Samarth −$2.6M Chief Executive Officer sold 14% of stake
  2. KASINGER JAMES R. −$797K General Counsel and Secretary sold 12% of stake
  3. Behbahani Ali −$781K Director sold 45% of stake
  4. George Simeon −$720K Director sold 48% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-12-16 Kulkarni Samarth Chief Executive Officer Option exercise +8,000 $1.81 $14K 172,320
2019-12-16 Kulkarni Samarth Chief Executive Officer Option exercise · Stock Option (Right to Buy) −8,000 195,058
2019-12-03 Klein Lawrence Otto Chief Business Officer Grant or award · Restricted Stock Units +40,000 40,000
2019-12-03 TOMSICEK MICHAEL JOHN Chief Financial Officer Grant or award · Restricted Stock Units +20,000 20,000
2019-12-03 Kulkarni Samarth Chief Executive Officer Grant or award · Restricted Stock Units +120,000 120,000
2019-12-03 Ho Tony W Executive VP, Head of R&D Grant or award · Restricted Stock Units +40,000 40,000
2019-12-03 KASINGER JAMES R. General Counsel and Secretary Grant or award · Restricted Stock Units +20,000 20,000
2019-12-01 Kulkarni Samarth Chief Executive Officer Shares withheld for taxes −741 $71.65 $53K 164,320
2019-11-19 Bolzon Bradley J PhD Director Sale −13,745 $67.41 $927K 0
2019-11-19 Bolzon Bradley J PhD Director Sale −28,255 $67.41 $1.9M 596,741
2019-11-19 Novak Rodger President Option exercise +33,618 $14.43 $485K 33,618
2019-11-19 Novak Rodger President Sale −33,618 $70.00 $2.4M 0
2019-11-19 Novak Rodger President Option exercise · Stock Option (Right to Buy) −33,618 236,382
2019-11-19 CAGNONI PABLO J Director Option exercise +7,500 $5.59 $42K 7,500
2019-11-19 CAGNONI PABLO J Director Sale −7,500 $62.00 $465K 0
2019-11-19 CAGNONI PABLO J Director Option exercise · Stock Option (Right to Buy) −7,500 63,833
2019-11-12 CAGNONI PABLO J Director Option exercise +7,500 $5.59 $42K 7,500
2019-11-12 CAGNONI PABLO J Director Sale −7,500 $55.00 $413K 0
2019-11-12 CAGNONI PABLO J Director Option exercise · Stock Option (Right to Buy) −7,500 71,333
2019-10-30 CAGNONI PABLO J Director Option exercise +7,500 $5.59 $42K 7,500

Page 45 of 46 · 910 trades